Ambrx Biopharma Inc

Renewed interest in ADCs will continue in 2024

by
Renewed interest in ADCs will continue in 2024

Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but promising group of cancer drugs was a red-hot market in 2023, and more companies could look to the treatments to fuel growth in the year ahead. … Read more

J&J to acquire Ambrx Biopharma, a cancer drug developer, for $2B

by
J&J to acquire Ambrx Biopharma, a cancer drug developer, for B

An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Monday said it will pay $2 billion in cash to acquire Ambrx Biopharma, a drugmaker specializing in one of the hottest areas of cancer treatment. … Read more